The approach is based on two popular AI techniques: generative adversarial networks and reinforcement learning.The news: A team from AI pharma startup Insilico Medicine, working with researchers at the University of Toronto, took 21 days to create 30,000 designs for molecules that target a protein linked with fibrosis (tissue scarring).
Continue reading...
No comments:
Post a Comment